We are live on ! Find out more
PKBO

Peak Bio, Inc. Common Stock

Delisted

PKBO was delisted on the 9th of January, 2023.

24 hedge funds and large institutions have $21.9M invested in Peak Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

60% more funds holding

Funds holding: 1524 (+9)

49% more capital invested

Capital invested by funds: $14.7M → $21.9M (+$7.24M)

Holders
24
Holders Change
+9
Holders Change %
+60%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
7
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
KPF
1
K2 Principal Fund
Ontario, Canada
$3.33M +$1.96M +200,892 +140%
SCM
2
Saba Capital Management
New York
$2.15M +$707K +72,579 +48%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$1.94M
DKCM
4
Davidson Kempner Capital Management
New York
$1.71M +$1.72M +176,209 New
KIM
5
Karpus Investment Management
New York
$1.6M +$36.5K +3,749 +2%
PC
6
Periscope Capital
Ontario, Canada
$1.45M
MP
7
Mangrove Partners
Connecticut
$1.23M
Citadel Advisors
8
Citadel Advisors
Florida
$1.11M +$1.73K +178 +0.2%
BCM
9
Basso Capital Management
Connecticut
$988K +$487K +50,000 +96%
BFM
10
Boothbay Fund Management
New York
$980K +$986K +101,200 New
RCM
11
Radcliffe Capital Management
Pennsylvania
$968K
ASM
12
ATW SPAC Management
New York
$968K +$974K +100,000 New
PAMP
13
Polar Asset Management Partners
Ontario, Canada
$726K
Jane Street
14
Jane Street
New York
$553K +$19.2K +1,974 +4%
CM
15
Cohanzick Management
New York
$488K +$491K +50,400 New
CH
16
CVI Holdings
Delaware
$387K
Millennium Management
17
Millennium Management
New York
$357K +$359K +36,847 New
LCM
18
Landscape Capital Management
New Jersey
$321K +$323K +33,112 New
BI
19
Bulldog Investors
New Jersey
$242K
CM
20
Crestline Management
Texas
$203K +$204K +20,924 New
RA
21
RiverPark Advisors
New York
$132K +$132K +13,586 New
WAM
22
Wolverine Asset Management
Illinois
$44K +$31.5K +3,238 +234%
PAM
23
Panagora Asset Management
Massachusetts
$18K +$17.6K +1,810 New
TRCT
24
Tower Research Capital (TRC)
New York
$1K +$945 +97 New
LA
25
Linden Advisors
New York
-$1.18M -121,857 Closed

PKBO Hedge Fund Activity: Q2 2021 in Review

24 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Common Stock (PKBO) for Q2 2021, worth a combined $21.9M — up 49% from $14.7M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new PKBO positions and 1 closed out — a net gain of 9 holders — while 7 added to existing stakes and 0 trimmed.

The largest buyer was K2 Principal Fund, adding an estimated $1.96M. The largest seller was Linden Advisors, exiting entirely with an estimated $1.18M sold.

  • 24 institutional investors held Peak Bio, Inc. Common Stock (PKBO) as of Q2 2021, up from 15 in Q1 2021.
  • Funds reported $21.9M of Peak Bio, Inc. Common Stock stock for Q2 2021, up 49% quarter-over-quarter.
  • 10 funds opened new Peak Bio, Inc. Common Stock positions in Q2 2021 and 1 closed out, a net change of +9 holders.
  • The largest Peak Bio, Inc. Common Stock buyer in Q2 2021 was K2 Principal Fund, an estimated $1.96M added.
  • The largest Peak Bio, Inc. Common Stock seller in Q2 2021 was Linden Advisors, an estimated $1.18M sold.

Based on aggregated 13F filings for Q2 2021.